Shortage of mucormycosis drugs to continue
Updated:
Updated:
Despite Kerala’s request, northern States get priority
Share Article
Despite Kerala’s request, northern States get priority
Shortage of amphotericin B and liposomal amphotericin B, the medicines used to treat patients with mucormycosis symptoms, is likely to continue for some more days in the State though the authorities are hopeful of procuring more doses very soon.
Liposomal amphotericin B is given as an injection to infected persons who are kidney patients and amphotericin B is for those without renal problems. Kidney patients need continuous medication and the drug is costlier too with the price per vial going up to ₹7,000.